Arsenal Biosciences
Private
Clinical-stage cell therapy company developing next-generation CAR-T cell therapies for solid tumors.
Company Info
Workforce & Restructuring Tracker
View Industry Layoff Tracker →99 roles (Majority of staff)WARN Notice
Programmable cell therapy developer ArsenalBio cut 99 employees (the majority of its workforce, including 58 South San Francisco HQ roles per CA WARN filings) as it discontinued its ex vivo clinical CAR-T programs to pivot to in vivo CAR-T delivery.
Recent News
No recent news updates available for this company.